- ￥2444
- BioXCell
- 美国
- SIM0046-1mg
- 2025年07月14日
企业认证
相关产品推荐更多 >
![ACETAMIDE,N-(2-METHYL-4-BENZO[D]IMIDAZOLYL)-](https://img1.dxycdn.com/p/s14/2025/0214/356/6929720261441720981.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
详询
- 保质期：
详询
- 英文名：
InVivoSIM anti-human CTLA-4 (Tremelimumab Biosimilar)
- 库存：
99
- 供应商：
北京孚博生物
- CAS号：
详询
- 规格：
1mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Markers for Anti-cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Therapy in Melanoma
Therapeutic strategies that block Cytotoxic T lymphocyte antigen-4 (CTLA-4) enhance antitumor immunity and prolong the lives of patients with metastatic melanoma. However, only a subset of patients benefit, and responses are often delayed
Collection, Separation, and Activation of Human T Lymphocytes
and is constitutively expressed on the surface of both CD4+ and CD8+ T lymphocytes (5 ,6 ). CD28 and its homolog CTLA-4 bind the natural ligands B7.1 and B7.2 (also known as CD80 and CD86, respectively), which are present on antigen presenting cells (APCs
Human CD4+CD25highCD127low/neg Regulatory T Cells
25, CD39/CD73, CD62L, CD45RO, CD127, glucocorticoid-induced tumor necrosis factor receptor (GITR), CTLA-4, and the forkhead/winged helix transcription factor (FOXP3), has been used to characterize Tregs. Tregs suppress T effector responses mainly
技术资料暂无技术资料 索取技术资料
